We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.02B
AUM Growth
+$434M
Cap. Flow
+$190M
Cap. Flow %
6.3%
Top 10 Hldgs %
45.02%
Holding
338
New
35
Increased
173
Reduced
106
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
301
Vertex Pharmaceuticals
VRTX
$120B
$207K 0.01%
+509
New +$188K
AMT icon
302
American Tower
AMT
$80.4B
$207K 0.01%
+959
New +$181K
ADMA icon
303
ADMA Biologics
ADMA
$2B
$205K 0.01%
45,267
PPG icon
304
PPG Industries
PPG
$25.2B
$204K 0.01%
+1,367
New +$185K
SHY icon
305
iShares 1-3 Year Treasury Bond ETF
SHY
$25B
$201K 0.01%
2,445
-657
-21% -$53.4K
INVA icon
306
Innoviva
INVA
$1.53B
$194K 0.01%
12,099
-260
-2% -$3.63K
GLAD icon
307
Gladstone Capital
GLAD
$433M
$173K 0.01%
8,066
-11
-0.1% -$220
GBDC icon
308
Golub Capital BDC
GBDC
$3.44B
$172K 0.01%
11,421
+325
+3% +$4.78K
PNNT
309
Pennant Park Investment Corp
PNNT
$223M
$168K 0.01%
+24,380
New +$157K
CGBD icon
310
Carlyle Secured Lending
CGBD
$715M
$167K 0.01%
11,188
-435
-4% -$6.33K
HBAN icon
311
Huntington Bancshares
HBAN
$34.9B
$165K 0.01%
13,010
-338
-3% -$3.7K
TCPC icon
312
BlackRock TCP Capital
TCPC
$283M
$165K 0.01%
+14,274
New +$162K
VLY icon
313
Valley National Bancorp
VLY
$8.01B
$157K 0.01%
14,500
TRIN icon
314
Trinity Capital Inc.
TRIN
$1.6B
$157K 0.01%
+10,815
New +$155K
CRF
315
Cornerstone Total Return Fund
CRF
$1.16B
$150K 0.01%
21,741
+1,006
+5% +$7.05K
FLG
316
Flagstar Bank National Association
FLG
$5.95B
$140K ﹤0.01%
4,575
+53
+1% +$1.59K
CLM icon
317
Cornerstone Strategic Value Fund
CLM
$2.21B
$139K ﹤0.01%
19,600
+1,011
+5% +$7.21K
VTRS icon
318
Viatris
VTRS
$20.4B
$110K ﹤0.01%
+10,174
New +$97.4K
NAK
319
Northern Dynasty Minerals
NAK
$835M
$103K ﹤0.01%
318,950
HRTX icon
320
Heron Therapeutics
HRTX
$96.6M
$81.4K ﹤0.01%
47,863
-1,116
-2% -$1.23K
REKR icon
321
Rekor Systems
REKR
$90.8M
$54.9K ﹤0.01%
16,500
+6,500
+65% +$18.5K
IBRX icon
322
ImmunityBio
IBRX
$7.55B
$50.2K ﹤0.01%
10,000
EOSE icon
323
Eos Energy Enterprises
EOSE
$1.35B
$43.6K ﹤0.01%
+40,000
New +$58.3K
MRSN
324
DELISTED
Mersana Therapeutics
MRSN
$36.3K ﹤0.01%
626
-19
-3% -$764
FUBO icon
325
FuboTV Inc
FUBO
$282M
$31.8K ﹤0.01%
833
-5
-0.6% -$173

Similar funds

Grimes & Company's Q4 2023 Portfolio in Review

As of Q4 2023, Grimes & Company held 338 positions worth $3.02B, up 17% from $2.59B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $190M of net new capital in Q4 2023, opening 35 new positions and adding to 173 existing holdings. Its largest new stake was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $163M trimmed.

  • Grimes & Company's largest Q4 2023 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.
  • Grimes & Company added most to iShares Core MSCI Emerging Markets ETF in Q4 2023, an estimated $83M increase.
  • Grimes & Company's biggest Q4 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $163M.
  • Grimes & Company fully exited State Street Financial Select Sector SPDR ETF in Q4 2023, selling an estimated $11.8M.
  • Grimes & Company's ten largest holdings make up 45% of its $3.02B portfolio in Q4 2023.
  • Grimes & Company opened 35 new positions and closed 7 in Q4 2023.
  • Grimes & Company's portfolio value rose 17% quarter-over-quarter to $3.02B.

Based on Grimes & Company's 13F filing for Q4 2023, filed 24 Jan 2024.